UAB Digital Repository of Documents 3 records found  Search took 0.00 seconds. 
1.
16 p, 967.2 KB Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs / Fuggle, N. R. (University of Southampton) ; Cooper, C. (University of Oxford) ; Harvey, N. C. (University of Southampton) ; Al-Daghri, Nasser (King Saud University) ; Brandi, M.-L. (University Hospital of Florence) ; Bruyere, O. (WHO Collaborating Centre for Public Health Aspects of Musculoskeletal Health and Aging, Liège, Belgium) ; Cano, A. (University of Valencia) ; Dennison, E. M. (University of Southampton) ; Diez-Perez, A. (Institut Hospital del Mar d'Investigacions Mèdiques) ; Kaufman, J.-M. (Universitair Ziekenhuis Gent) ; Palacios, S. (The Palacios Institute of Women's Health, Madrid) ; Prieto-Alhambra, D. (University of Oxford) ; Rozenberg, S. (CHU St Pierre, Bruxelles) ; Thomas, T. (CHU de Saint-Etienne, France) ; Tremollieres, F. (Toulouse University Hospital) ; Rizzoli, R. (Hôpitaux Universitaires Genève) ; Kanis, J. A. (Australian Catholic University) ; Reginster, J. Y. (King Saud University) ; Universitat Autònoma de Barcelona
The incidence of osteoporosis and cardiovascular disease increases with age, and there are potentially shared mechanistic associations between the two conditions. It is therefore highly relevant to understand the cardiovascular implications of osteoporosis medications. [...]
2020 - 10.1007/s40265-020-01364-2
Drugs, Vol. 80 (july 2020) , p. 1537-1552  
2.
14 p, 433.6 KB Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for Osteoporosis / Lorentzon, M. (University of Gothenburg) ; Branco, J. (NOVA University of Lisbon) ; Brandi, M.L. (University of Florence) ; Bruyère, O. (University of Liège) ; Chapurlat, R. (Université de Lyon) ; Cooper, C. (University of Southampton) ; Cortet, B. (CHU Lille) ; Díez Pérez, Adolfo (Institut Hospital del Mar d'Investigacions Mèdiques) ; Ferrari, S. (Geneva University Hospital) ; Gasparik, A. (University of Medicine, Pharmacy, Science and Technology of Targu Mures) ; Herrmann, M. (Medical University of Graz) ; Jorgensen, N.R. (Copenhagen University Hospital Rigshospitalet) ; Kanis, J. (Mary MacKillop Institute for Health Research) ; Kaufman, J.M. (Ghent University Hospital) ; Laslop, A. (Austrian Agency for Health and Food Safety) ; Locquet, M. (University of Liège) ; Matijevic, Radmila (University of Novi Sad) ; McCloskey, E. (University of Sheffield) ; Minisola, S. (Sapienza Università di Roma) ; Pikner, R. (Klatovska Hospital, Klatovy, Czech Republic) ; Reginster, J.Y. (University of Liège) ; Rizzoli, R. (Geneva University Hospital) ; Szulc, P. (Université de Lyon) ; Vlaskovska, M. (Medical University Sofia) ; Cavalier, E. (University of Liège) ; Universitat Autònoma de Barcelona
Introduction: Increased biochemical bone turnover markers (BTMs) measured in serum are associated with bone loss, increased fracture risk and poor treatment adherence, but their role in clinical practice is presently unclear. [...]
2019 - 10.1007/s12325-019-01063-9
Advances in Therapy, Vol. 36 Núm. 10 (january 2019) , p. 2811-2824  
3.
12 p, 675.8 KB Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer : Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG / Hadji, Peyman (Krankenhaus Nordwest) ; Aapro, Matti S. (Genolier Cancer Center, Switzerland) ; Body, Jean-Jacques (CHU Brugmann, Université Libre de Bruxelles, Belgium) ; Gnant, Michael (Medical University of Vienna, Austria) ; Brandi, Maria Luisa (University of Florence, Italy) ; Reginster, Jean Yves (University of Liège, Belgium) ; Zillikens, M. Carola (Erasmus MC, Rotterdam, Netherlands) ; Glüer, Claus-C. (Univeristy of Kiel, Germany) ; de Villiers, Tobie (University of Stellenbosch, Cape Town, South Africa) ; Baber, Rod (University of Sydney, Australia) ; Roodman, G. David (Indiana University School of Medicine, USA) ; Cooper, Cyrus (University of Southampton, UK) ; Langdahl, Bente (Aarhus University, Denmark) ; Palacios, Santiago (Instituto Palacios Madrid, Spain) ; Kanis, John (Catholic University of Australia, Melbourne, Australia and University of Sheffield, UK) ; Al-Daghri, Nasser (University of Riyadh, Saudi Arabia) ; Nogués Solán, Xavier (Universitat Autònoma de Barcelona) ; Eriksen, Erik Fink (University of Oslo, Norway) ; Kurth, Andreas (Klinikum Birkenwerder, Germany) ; Rizzoli, Rene (Geneva University, Switzerland) ; Coleman, Robert E. (University of Sheffield, UK)
Several guidelines have been reported for bone-directed treatment in women with early breast cancer (EBC) for averting fractures, particularly during aromatase inhibitor (AI) therapy. Recently, a number of studies on additional fracture related risk factors, new treatment options as well as real world studies demonstrating a much higher fracture rate than suggested by randomized clinical controlled trials (RCTs). [...]
2017 - 10.1016/j.jbo.2017.03.001
Journal of Bone Oncology, Vol. 7 (June 2017) , p. 1-12  

See also: similar author names
1 Brandi, M.-L.
3 Brandi, Maria Luisa
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.